A Study Evaluating the Use of an Indoor Air Quality Monitor to Promote a Smoke-free Home

The purpose of this study is to evaluate how using an indoor air quality monitor can promote a smoke-free home for cancer patients who are enrolled in MSK's Tobacco Treatment Program.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Smoking Behavior Behavior, Addictive Cigarette Smoking Compulsive Behavior Health Behavior Impulsive Behavior Smoking (Tobacco) Addiction Smoking Behaviors Smoking Cessation Smoking Habit Smoking Reduction Smoking, Cigarette Smoking, Tobacco Tobacco Smoking Tobacco Use

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Memorial Sloan Kettering Basking Ridge (Consent only), Basking Ridge, New Jersey, United States

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Adult (aged >18 years) MSK patients as per the EHR
Has been referred and enrolled in the MSK TTP and completed the initial counseling session as per the TTP clinical database
Reports current (within the past 30 days) tobacco use (i.e., cigarettes and/or any other tobacco products) as per the TTP Intake form
Must be English-speaking in the EHR
Must be reachable by phone as per self-report
Must have Wi-Fi available at home as per self-report

Exclusion criteria

Patient reports that no smoking is allowed, by them or anyone else, in the home as per the TTP intake form and/or per self-report

Treatment and study plan

Indoor Air Quality Monitor AirGradient ONE

Other

Participants will be asked to set up an Indoor Air Quality Monitor AirGradient ONE (Model: I-9PSL) which is an award winning commercially available indoor air quality monitor designed to enable anyone to monitor their air quality in their home for about 60 days (8 weeks). Indoor air pollution levels within participating households will be measured using these AQMs.

Primary outcomes

Percentage of participants using the air quality monitoring device for 14 consecutive days

Time frame: up to 8 weeks

Assess the feasibility and acceptability of collecting environmental data on biomarkers of household air quality (AQ) and smoke exposure using low-cost, AQMs as an intermediate endpoint of a smoke-free-home.
Percentage of participants who attend the study-specific smoke-free workshop sessions

Time frame: Up to 8 weeks

Assess the feasibility and acceptability of tobacco treatment adherence among individuals diagnosed with cancer.

Study contacts

Contact information is provided by the study sponsor or research team.

Gleneara Bates-Pappas, PhD, LMSW

CONTACT

[email protected]

212-610-0507

Michael Bellamy, PhD

CONTACT

[email protected]

212-639-2045

Sponsors and collaborators

Lead sponsor

Memorial Sloan Kettering Cancer Center

Other

Registry information

Official study title

Freedom to Breathe: Pilot Study Towards Achieving Environmental Justice for Cancer Patients and Their Families

Important dates

Study start: 2024
Primary completion: 2027
Study completion: 2027
First posted: Nov 18, 2024
Registry last updated: Oct 22, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed